Efficacy and safety of dulaglutide monotherapy compared with glimepiride in East ‐Asian patients with type 2 diabetes in a multicentre, double‐blind, randomized, parallel‐arm, active comparator, phase III trial

Diabetes, Obesity and Metabolism, EarlyView.

Source: Diabetes, Obesity and Metabolism - June 6, 2018 Category: Endocrinology Authors: Yu Hong Chen MD , Chien ‐Ning Huang MD , Young Min Cho MD , Pengfei Li PhD , Liqun Gu MD , Feng Wang MD , Jun Yang MD , Wei Qing Wang MD Source Type: research